How many stocks are there of Cann Group?
The current number of stocks of Cann Group is 372.25 M undefined.
Cann Group Stocks 2024
Cann Group Stocks
372.25 M
Ticker
CAN.AX
ISIN
AU000000CAN2
WKN
A2DSUQ
In 2024, Cann Group had 372.25 M outstanding stocks, a 0% change from the 372.25 M stocks in the previous year.
The Cann Group Stocks history
| YEAR | NUMBER OF STOCKS (undefined AUD) |
|---|---|
| 2025e | 372.25 |
| 2024e | 372.25 |
| 2023 | 372.25 |
| 2022 | 337.79 |
| 2021 | 259.46 |
| 2020 | 143.33 |
| 2019 | 139.69 |
| 2018 | 125.28 |
| 2017 | 108.35 |
| 2016 | 108.35 |
| 2015 | - |
Cann Group shares outstanding AU000000CAN2 · A2DSUQ
The number of shares was Cann Group in 2023 — This indicates how many shares 372.252 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Cann Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Cann Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Cann Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cann Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2015 | 0 Aktien |
| 2016 | 108.35 M Aktien |
| 2017 | 108.35 M Aktien |
| 2018 | 125.28 M Aktien |
| 2019 | 139.69 M Aktien |
| 2020 | 143.33 M Aktien |
| 2021 | 259.46 M Aktien |
| 2022 | 337.79 M Aktien |
| 2023 | 372.25 M Aktien |
| 2024e | 372.25 M Aktien |
| 2025e | 372.25 M Aktien |
Cann Group Aktienanalyse
What does Cann Group do?
Cann Group Ltd is an Australian company specializing in the production and marketing of medical cannabis. The company was founded in 2013 and is headquartered in Melbourne. The company's history began with the founding of an independent consulting firm called AusCann Group Holdings Ltd in 2014. This firm was created to inform Australian and international investors about the opportunities and possibilities in the Australian cannabis market. In 2016, a cooperation agreement was signed between AusCann and Cann Group Ltd to advance the cultivation and production of medical cannabis products in Australia. Since then, Cann Group has continuously invested in the development and growth of the Australian medical cannabis market. The company has obtained a Good Manufacturing Practices (GMP) compliance license to ensure that all products meet the highest quality and safety standards. This includes collaborating with research institutions and state health authorities to investigate the efficacy and safety of medications. Cann Group's various business areas include the production of medical cannabis, research, product development, and marketing. The company operates a cannabis cultivation facility in Cochranes Hill, Victoria, covering an area of 20 hectares. The cultivation of cannabis is carried out under controlled conditions to ensure that all products are of the highest quality and purity. The cultivated cannabis is then used to manufacture medical products such as oils, tinctures, capsules, and sprays. Cann Group also collaborates closely with research institutions and academic institutions to study the safety and efficacy of medical cannabis. The company has partnerships with the University of Melbourne, Queensland University of Technology, and Swinburne University of Technology for research on the mechanisms of cannabis, application research, and studies on the clinical efficacy of cannabis. The business model of Cann Group is based on the sale of medical cannabis products to pharmacies and medical facilities in Australia and worldwide. The company, through its license, is one of the few companies capable of producing and exporting medical cannabis for the Australian market. In addition to exporting cannabis products to Germany, New Zealand, the UK, and other countries, the sale of cannabis products to the Australian market is the largest market for Cann Group. The company offers a variety of medical cannabis products specifically developed for various medical conditions. These include products for anxiety, nausea and vomiting, pain, seizures, and many other diseases. There are also products for palliative care, which help alleviate pain and suffering in the final stages. Overall, Cann Group Ltd has played a pioneering role in the development of the Australian medical cannabis market in recent years. The company specializes in the production of medical cannabis products that meet the highest quality standards and strict regulatory requirements. The company is committed to improving the therapeutic approach to diseases and enhancing the quality of life for patients. Cann Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Cann Group's Shares Outstanding
Cann Group's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Cann Group’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Cann Group’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Cann Group’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Cann Group stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Cann Group are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Cann Group evolved in recent years?
The number of shares of Cann Group has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Cann Group as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Cann Group?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Cann Group pay?
Over the past 12 months, Cann Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cann Group is expected to pay a dividend of 0 AUD.
What is the dividend yield of Cann Group?
The current dividend yield of Cann Group is .
When does Cann Group pay dividends?
Cann Group pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cann Group?
Cann Group paid dividends every year for the past 0 years.
What is the dividend of Cann Group?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cann Group located?
Cann Group is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cann Group kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cann Group from 9/11/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/11/2024.
When did Cann Group pay the last dividend?
The last dividend was paid out on 9/11/2024.
What was the dividend of Cann Group in the year 2023?
In the year 2023, Cann Group distributed 0 AUD as dividends.
In which currency does Cann Group pay out the dividend?
The dividends of Cann Group are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cann Group
Our stock analysis for Cann Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cann Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
